NLE Neurosensory Nursing — Sensory Disorders of the Eye and EarCheat Sheet

Common Values

Section Title

ANATOMY QUICK REVIEW: Eye Structure & Function

Important Facts

• Light pathway: cornea → pupil → lens → retina → optic nerve (CN II)
• Ciliary body produces aqueous humor continuously; normal IOP depends on balance between production and drainage
• The cornea provides 70% of the eye's refractive power; the lens provides adjustable focus (accommodation)
• The optic nerve carries 1.2 million axons from retinal ganglion cells; optic nerve damage in glaucoma is irreversible
• Normal vision requires intact pathway from cornea through retina to visual cortex

Key Definitions

Diagrams To Know

• Sagittal cross-section of the eye showing aqueous humor production and drainage pathway
• Light refraction through the lens and focus on the retina

Section Title

CATARACT: The Painless Lens Opacity

Important Facts

• PAINLESS, gradual onset — patient describes glare, halos around lights, blurred vision, faded colors, difficulty reading
• Risk factors: aging, diabetes, corticosteroid use (especially systemic), trauma, UV exposure, smoking
• Examination findings: diminished red reflex, white/opaque lens on inspection, decreased visual acuity
• Treatment is ELECTIVE, scheduled when cataract interferes with daily function — not based on density alone
• Surgery is a same-day procedure; patient is awake but anesthetized

Key Definitions

Diagrams To Know

• Lens opacity progression: clear lens → early haze → mature cataract → hypermature (shrunken) cataract
• Cross-section showing lens opacity blocking light transmission

Section Title

CATARACT SURGERY & POSTOPERATIVE CARE: The IOP-Raising Minefield

Important Facts

• PRIORITY: Prevent increased IOP postoperatively — this is the #1 cause of complications and vision loss
• ABSOLUTE CONTRAINDICATIONS after surgery: bending, lifting (>5 lbs), Valsalva, coughing, sleeping on operative side
• ALWAYS wear eye shield day and night; dark glasses to reduce photophobia and glare
• Use topical antibiotic and corticosteroid drops as prescribed — prevent infection and control inflammation
• Report IMMEDIATELY: sudden severe eye pain (hemorrhage), decreased vision, increased discharge (infection), halos/blurred vision (elevated IOP)
• Slight irritation, tearing, and mild discomfort are NORMAL; severe pain is NOT and requires urgent evaluation
• Sutures, if non-dissolving, are removed in 2–4 weeks; activity restrictions last 4–6 weeks
• Vision stabilization occurs over 4–6 weeks; final refraction done after this period

Key Definitions

Diagrams To Know

• Factors that raise IOP postoperatively: Valsalva, bending, lifting, straining, coughing, prone position

Common Values

Section Title

GLAUCOMA: Irreversible Optic Nerve Damage – Two Faces

Important Facts

• Leading cause of PREVENTABLE BLINDNESS in the Philippines and worldwide
• IOP elevation alone does NOT diagnose glaucoma; must have optic nerve damage (cupping) or visual-field loss
• Optic nerve damage is IRREVERSIBLE — once lost, vision cannot be restored; goal is to halt progression
• Vision loss is SILENT and PAINLESS in open-angle glaucoma; patients often unaware until peripheral vision is significantly lost
• Screening (tonometry, optic disc examination, visual-field testing) is the ONLY way to detect early disease
• Risk factors: age >40, family history of glaucoma, elevated IOP, African descent, diabetes, hypertension, high myopia, corticosteroid use

Key Definitions

Diagrams To Know

• Normal vs. glaucomatous optic disc (cupping progression)
• Visual-field defects in open-angle glaucoma (arcuate scotoma, nasal step, peripheral depression)

Section Title

PRIMARY OPEN-ANGLE GLAUCOMA: The Silent Thief

Important Facts

• ASYMPTOMATIC early — no pain, no red eye, no blurred vision until advanced
• GRADUAL onset — IOP rises slowly over months to years; peripheral vision lost gradually (patient often unaware)
• The phrase 'silent thief of sight' captures its insidious nature
• Peripheral vision is lost FIRST and LAST (central vision goes late); this is why patients may not notice early loss
• Diagnosis requires COMBINATION: elevated IOP + optic disc changes (cupping) + visual-field defects on perimetry
• Goldmann applanation tonometry and slit-lamp examination are standard diagnostic tools
• Regular screening every 1–2 years is recommended for all adults >40, especially high-risk groups
• Treatment is LIFELONG with topical medications; goal is to halt visual-field loss and optic nerve damage progression

Key Definitions

Diagrams To Know

• Cross-section of open drainage angle showing impaired aqueous outflow through trabecular meshwork

Common Values

Section Title

ACUTE ANGLE-CLOSURE GLAUCOMA: The Ophthalmic Emergency

Important Facts

• ACUTE presentation with SEVERE ocular and systemic symptoms — distinguish from POAG immediately
• Classic triad: SUDDEN SEVERE eye pain + headache + vision changes (halos, blurred vision)
• Associated symptoms: red eye, corneal edema (steamy appearance), fixed MID-DILATED pupil (not fully dilated, not constricted), nausea/vomiting
• IOP is VERY HIGH (>40 mmHg), often measured in the 40–70 mmHg range
• Risk factors: angle-closure anatomy (long eyes, shallow anterior chamber, thick lens, hyperopia), pupil dilation (dim lighting, mydriatic drugs)
• MEDICAL EMERGENCY — untreated angle-closure causes BLINDNESS within 24–48 hours
• Immediate treatment: topical miotics (pilocarpine), systemic acetazolamide, osmotic agents (IV mannitol, oral glycerol), IV beta-blockers
• Definitive treatment: URGENT laser peripheral iridotomy (within hours); may need fellow eye prophylactic iridotomy
• After iridotomy, drainage angle opens, IOP normalizes, and symptoms resolve rapidly
• Prophylactic iridotomy recommended for at-risk fellow eyes to prevent acute attack

Key Definitions

Diagrams To Know

• Narrow vs. normal drainage angle anatomy showing iris blocking angle
• Mechanism of acute angle closure: pupil dilates, iris bows forward, blocks drainage angle

Section Title

OPEN-ANGLE vs. ANGLE-CLOSURE GLAUCOMA: Exam Differentiator

Important Facts

• This comparison is HEAVILY tested on the NLE — examiners love this distinction
• Presentation, urgency, and management differ DRAMATICALLY
• Open-angle = chronic, asymptomatic, regular screening, topical drugs, laser trabeculoplasty, filtration surgery
• Angle-closure = acute, symptomatic emergency, immediate treatment, urgent laser iridotomy

Section Title

GLAUCOMA MEDICATIONS: Mechanisms & Nursing Priorities

Important Facts

• Glaucoma drops LOWER IOP and are taken LIFELONG; skipping doses risks vision loss
• FIRST-LINE: Prostaglandin analogs — latanoprost, travoprost, bimatoprost (increase aqueous outflow)
• SIDE EFFECTS of prostaglandin analogs: iris darkening (permanent), eyelash growth/darkening, conjunctival hyperemia
• BETA-BLOCKERS (timolol, betaxolol): decrease aqueous production; use punctal occlusion and monitor for systemic beta-blockade
• ABSOLUTE CONTRAINDICATION of non-selective beta-blockers: asthma, COPD, bradycardia, heart block, hypotension
• ALPHA-2 AGONISTS (brimonidine, apraclonidine): reduce aqueous production and increase uveoscleral outflow; local allergy common
• CARBONIC ANHYDRASE INHIBITORS: dorzolamide (topical), acetazolamide (systemic) — decrease aqueous production; acetazolamide causes metabolic acidosis, paresthesias
• CHOLINERGIC MIOTICS (pilocarpine): constrict pupils to open drainage angle — especially useful in angle-closure; causes headache, accommodation spasm
• RHOKINASE INHIBITORS (netarsudil): newer class; increase conventional and uveoscleral outflow; conjunctival hyperemia common
• COMBINATION DROPS: many 2-drug combinations available; check compatibility before mixing separate drops
• INSTILLATION TECHNIQUE: 5-minute interval between different drugs; instill suspensions/ointments last

Key Definitions

Diagrams To Know

• Aqueous humor pathways: conventional (trabecular meshwork) vs. uveoscleral; which drugs target which pathway

Section Title

RETINAL DETACHMENT: The Urgent Surgical Emergency

Important Facts

• PAINLESS — retina has no pain fibers; patient feels NO pain despite urgent pathology
• Classic presentation triad: SUDDEN floaters + FLASHES of light + CURTAIN/SHADOW spreading across visual field
• The 'curtain' or 'shadow' corresponds to the area of detached retina; progresses toward center if untreated
• Visual loss is PROGRESSIVE but PAINLESS — patient may ignore early symptoms until vision is significantly affected
• Risk factors: high myopia, prior eye surgery, vitreous traction, family history, trauma, diabetic retinopathy, retinopathy of prematurity
• Acute, sudden onset is common; some detachments are slowly progressive (chronic traction detachments)
• Diagnosis: dilated fundus examination by ophthalmologist; ultrasound if media opacity prevents visualization
• URGENT SURGICAL REPAIR required to restore vision — delay results in permanent vision loss
• Types of repair: scleral buckling (external), pneumatic retinopexy (gas bubble), vitrectomy with endolaser or cryotherapy

Key Definitions

Diagrams To Know

• Cross-section showing detached retina separated from underlying RPE and choroid
• Progress of detachment from peripheral break toward central macula

Section Title

RETINAL DETACHMENT SURGERY: Position & Precautions

Important Facts

• Preoperative: restrict activity as ordered; position head/body to keep detached area in dependent position to prevent further detachment
• Postoperative with GAS BUBBLE: MANDATORY head positioning (often face-down or head-in-specific direction) for weeks; gas is gradually absorbed
• CANNOT fly or travel to high altitude with gas bubble in eye — pressure changes cause dangerous expansion
• CANNOT use air-filled contacts after gas injection until gas completely resorbed (check with ophthalmologist)
• Vision is blurred initially but improves as gas is absorbed and replaced with natural aqueous humor
• Postoperative pain control is important; patient will experience discomfort with prolonged positioning
• Teach specific positioning exercises and monitor compliance — proper positioning is critical to surgical success
• Report immediately: sudden vision loss, severe pain, floaters/flashes (recurrent detachment), discharge/redness (infection)
• Activity restrictions (no lifting, straining, bending) last 4–6 weeks as with cataract surgery
• Final visual acuity depends on whether macula was detached and duration of detachment before repair

Key Definitions

Diagrams To Know

• Gas bubble positioning as internal splint; mandatory head positioning to maintain tamponade

Section Title

OTITIS EXTERNA: Swimmer's Ear

Important Facts

• Causes: water in ear canal, ear-canal trauma (cotton swabs, fingernails, hearing aids), bacterial or fungal infection, dermatitis
• Most common organisms: Pseudomonas aeruginosa, Staphylococcus aureus, fungi (Aspergillus, Candida)
• Presentation: ear pain (often severe), worse with jaw movement or auricle manipulation, itching, drainage (serous, purulent, or hemorrhagic), temporary hearing loss if canal is swollen
• Examination: swollen, erythematous canal; may see exudate or debris
• Treatment: topical antibiotic/steroid drops (neomycin-polymyxin B-hydrocortisone, fluoroquinolone drops); oral antibiotics if systemic infection
• Prevention/teaching: keep ears dry after swimming (alcohol or vinegar drops, dry cotton), avoid insertion of foreign objects, do not pick at ears

Key Definitions

Section Title

OTITIS MEDIA: Middle-Ear Infection in Children

Important Facts

• Most common in children <3 years because Eustachian tubes are shorter, more horizontal, narrower, and more compliant
• Viral URI precedes bacterial infection; fluid accumulation causes pain and temporary hearing loss
• Organisms: Streptococcus pneumoniae, Haemophilus influenzae type b, Moraxella catarrhalis, Group A Streptococcus
• Acute otitis media (AOM): ear pain, fever, bulging erythematous TM, possible perforation with drainage
• Otitis media with effusion (OME): fluid behind TM without acute infection; asymptomatic or mild hearing loss; may persist weeks after AOM
• Treatment: analgesics (acetaminophen, ibuprofen), antibiotics if bacterial (amoxicillin first-line), nasal decongestants
• Spontaneous perforation relieves pain and drains pus but risks chronic suppurative otitis and conductive hearing loss
• Tympanostomy tubes indicated for: recurrent AOM (≥4 in 6 months), persistent OME >3 months with hearing loss, recurrent AOM with OME
• Teaching: complete full course of antibiotics, warm compress for pain, keep ear dry if TM is perforated, prevent water entry if tubes present

Key Definitions

Diagrams To Know

• Eustachian tube anatomy: child vs. adult — angle and length differences

Section Title

MÉNIÈRE'S DISEASE: The Triad of Terror

Important Facts

• Classic TRIAD: (1) EPISODIC VERTIGO (sudden, severe, spinning, unpredictable), (2) TINNITUS (ringing/roaring, often low-frequency), (3) FLUCTUATING SENSORINEURAL HEARING LOSS
• Fourth symptom often present: aural fullness (pressure sensation in the affected ear)
• Vertigo attacks last MINUTES to HOURS (typically 20 minutes to 2 hours); nausea and vomiting often accompany vertigo
• Hearing loss FLUCTUATES early in disease but may become permanent if disease progresses
• PATHOPHYSIOLOGY: Excess endolymph distends the membranous labyrinth, disrupting vestibular and cochlear function
• Etiology is unclear but may be related to: osmotic imbalance, fluid metabolism disorder, viral infection, autoimmune mechanism
• Typically UNILATERAL (one ear affected) but can become bilateral in 10–15% of cases
• Diagnosed by: history, audiometry (low-frequency sensorineural loss), caloric testing (vestibular dysfunction), MRI to rule out other pathology
• Onset typically ages 20–50 years; onset after age 60 is unusual and warrants investigation for other causes
• UNPREDICTABLE attacks make daily life extremely difficult; patients fear sudden onset while driving or at work

Key Definitions

Diagrams To Know

• Inner-ear anatomy showing cochlea, vestibule, semicircular canals, and membranous labyrinth with endolymph
• Effect of endolymphatic hydrops on Reissner's membrane and sensory cells

Common Values

Section Title

MÉNIÈRE'S DISEASE MANAGEMENT: Medical & Lifestyle

Important Facts

• PRIORITY during acute attack: SAFETY FIRST — prevent falls and injury from severe vertigo
• Acute attack management: bed rest in quiet, darkened room; patient remains still (any head movement worsens vertigo)
• Medications for acute vertigo: vestibular suppressants (meclizine), antiemetics (metoclopramide, prochlorperazine), anticholinergics (scopolamine)
• Chronic management: LOW-SODIUM DIET (<2 g/day) — reduces fluid retention and endolymphatic volume
• Diuretics (thiazide, loop diuretics) help some patients by promoting fluid loss
• Avoid TRIGGERS: caffeine, alcohol, nicotine — all can worsen symptoms by affecting inner-ear fluid balance
• Vestibular rehabilitation exercises may help reduce vertigo with time and improve balance
• Hearing aids if hearing loss is significant
• If medical management fails, surgical options: endolymphatic sac surgery, labyrinthectomy (destroys vestibular function), or vestibular nerve section
• Teaching: avoid sudden head movements, change positions slowly, do not drive during attacks, use assistive devices if balance is affected
• Psychological support important — chronic unpredictable vertigo causes anxiety and depression; counseling and support groups helpful

Key Definitions

Diagrams To Know

• Pathophysiology loop: increased endolymph → increased pressure → hair cell dysfunction → vertigo, tinnitus, hearing loss

Section Title

HEARING LOSS: Conductive vs. Sensorineural

Important Facts

• Conductive loss: problem is BEFORE the inner ear (outer/middle ear); sound is present but not transmitted
• Sensorineural loss: problem is IN/AFTER the inner ear (cochlea/CN VIII); sound transmission is intact but perception is damaged
• Conductive causes: cerumen impaction, otitis media/effusion, perforated TM, otosclerosis, cholesteatoma, malleus/incus/stapes fixation
• Sensorineural causes: aging (presbycusis), noise exposure, ototoxic drugs, viral infections (measles, mumps, rubella), meningitis, head trauma, acoustic neuroma, Ménière's disease, sudden sensorineural hearing loss (SSNHL)
• Weber TEST INTERPRETATION: normally heard equally; lateralizes to WORSE ear in CONDUCTIVE loss; lateralizes AWAY from WORSE ear in SENSORINEURAL loss
• Rinne TEST INTERPRETATION: normal is AC > BC (air conduction louder); in CONDUCTIVE loss, BC > AC (bone conduction louder)
• Combined conductive and sensorineural loss ('mixed' loss) also occurs
• Audiometry (pure-tone and speech audiometry) is gold standard for documenting type and degree of loss
• Conductive loss is often correctable: remove cerumen, treat otitis media, surgical repair (ossiculoplasty, stapes surgery)
• Sensorineural loss is usually permanent; management focuses on amplification (hearing aids), cochlear implants for severe loss, and communication strategies

Key Definitions

Diagrams To Know

• Sound pathway: external ear → tympanic membrane → ossicles → oval window → cochlea → CN VIII → auditory cortex
• Weber and Rinne test interpretation flowchart

Section Title

OTOTOXIC MEDICATIONS: Hearing Loss & Tinnitus Risk

Important Facts

• Aminoglycosides (gentamicin, tobramycin, amikacin): HIGH OTOTOXICITY — dose-dependent and cumulative; monitor serum levels; check baseline hearing before starting
• Loop diuretics (furosemide, bumetanide): ototoxic especially in HIGH DOSES or with renal impairment; risk increases when combined with aminoglycosides ('synergistic')
• High-dose aspirin and NSAIDs (salicylates): reversible tinnitus and hearing loss; typically high-frequency loss; resolves after drug discontinuation
• Chemotherapy agents (cisplatin, carboplatin): severe irreversible ototoxicity; high-frequency sensorineural loss; cumulative dose-dependent
• Macrolide antibiotics (azithromycin, erythromycin): less common but possible ototoxicity
• Vancomycin: possible ototoxicity, especially with high trough levels or renal impairment
• RISK FACTORS for ototoxicity: high drug dose, prolonged duration, renal impairment, dehydration, age >60, baseline hearing loss, concomitant ototoxic drugs, liver disease
• SYNERGISTIC EFFECT: combining multiple ototoxic drugs (e.g., gentamicin + furosemide + NSAIDs) increases risk dramatically
• Early signs: tinnitus (ringing/buzzing), high-frequency hearing loss, difficulty hearing consonants in conversation
• Baseline and periodic audiometry recommended for patients on known ototoxic drugs; discontinue if hearing loss develops
• Prevention: use lowest effective dose, monitor serum drug levels, maintain adequate hydration, avoid nephrotoxic combinations, educate patients about symptoms

Key Definitions

Diagrams To Know

• Common ototoxic drugs by category and risk level

Section Title

SUDDEN SENSORINEURAL HEARING LOSS (SSNHL): Medical Emergency

Important Facts

• Defined as loss of ≥30 dB in ≥3 consecutive frequencies over ≤3 days
• UNILATERAL in >90% of cases; bilateral SSNHL is rare and suggests systemic disease
• Incidence: ~2–5 per 10,000 per year in the Philippines and worldwide
• Possible etiologies: viral infection (labyrinthitis), vascular insufficiency, autoimmune inner-ear disease, trauma, neoplasm (acoustic neuroma), idiopathic (~70%)
• Urgent evaluation: audiometry, MRI to rule out acoustic neuroma or other pathology, CBC, metabolic panel, serologies
• Prognosis: ~50% recover spontaneously; early treatment improves outcomes
• Treatment (controversial but widely used): systemic corticosteroids (oral prednisone or IV methylprednisolone) — most effective if started within 2 weeks
• Intratympanic corticosteroid injections used as salvage therapy
• Antiviral therapy (acyclovir, valacyclovir) sometimes used if viral etiology suspected
• Patient education: this is a medical emergency; seek evaluation immediately; prognosis depends on early treatment

Key Definitions

Section Title

COMMUNICATION WITH HEARING-IMPAIRED PATIENTS

Important Facts

• FACE THE PATIENT — position yourself directly in front, at eye level; do not speak from behind or to the side
• Speak CLEARLY and at NORMAL PACE — do not shout (distorts speech) or speak too slowly
• Use a LOWER PITCH — high-pitched voices are harder to hear in sensorineural loss (especially presbycusis)
• REDUCE BACKGROUND NOISE — move to a quiet area if possible; background talking/music makes hearing aid use less effective
• Use WRITTEN COMMUNICATION if verbal is ineffective — written notes, phone text, email
• USE VISUAL AIDS — demonstrate, draw pictures, use hand gestures to clarify
• Ensure HEARING AID is functioning — check battery, proper fitting, volume setting
• Allow extra TIME for communication — be patient; do not rush
• REPEAT using different words if patient does not understand — rephrase rather than repeat the exact same phrase
• Verify understanding by asking patient to REPEAT back important instructions (teach-back method)
• Involve FAMILY or CAREGIVERS if available to assist with communication
• Use PROFESSIONAL INTERPRETERS or TTY/videophone services if available in healthcare setting

Key Definitions

Common Values

Section Title

EYE DROP INSTILLATION TECHNIQUE: Perfect Practice

Important Facts

• CLEAN HANDS thoroughly before instillation — prevent infection
• Tilt HEAD BACK and pull DOWN LOWER LID to form a small pocket
• Instill DROP into the CONJUNCTIVAL SAC (not directly on cornea, not on lid margin)
• Do NOT touch the DROPPER TIP to the eye or lid (contamination risk)
• Close EYE gently (do not squeeze) and hold for 1–2 minutes to allow absorption
• PUNCTAL OCCLUSION: Press gently on the medial canthus (tear duct area) for 1–2 minutes after instillation to block nasolacrimal drainage and reduce systemic absorption
• If MULTIPLE DROPS are ordered, wait 5 MINUTES between different medications to allow absorption and avoid wash-out
• Install SUSPENSIONS or OINTMENTS LAST (after liquid drops) — these are thicker and may block absorption of other drops
• OINTMENTS: instill a ribbon ~1/4 inch in the lower conjunctival sac; blurred vision is expected; use at bedtime
• Avoid rubbing the eye — removes medication and may cause irritation
• If drop misses the eye, do NOT re-instill immediately — wait until next scheduled time
• Reusable dropper bottles: cleanliness essential; single-use droppers safer

Key Definitions

Diagrams To Know

• Step-by-step diagram of proper eye-drop instillation technique

Section Title

SAFE ENVIRONMENT FOR VISUALLY IMPAIRED PATIENTS

Important Facts

• ANNOUNCE YOUR PRESENCE — identify yourself by name and role before approaching the patient
• ORIENT the patient to the environment — describe room layout, location of bathroom, call bell, personal belongings
• Keep ENVIRONMENT SAFE and CLUTTER-FREE — remove obstacles, trailing cables, furniture in walkways; risk of falls is HIGH
• CONSISTENT PLACEMENT of personal items — bedside table, chair, bathroom — so patient can locate them independently
• Provide VERBAL CUES for navigation — 'bed is to your right,' 'three steps to the bathroom'
• Use HANDRAILS and GUIDANCE when ambulating — hold the patient's arm; do not grab and pull
• Offer an ARM or ELBOW for guiding during ambulation — do not grab or push
• LIGHTING appropriate to condition — brighter for those with residual vision, softer for photophobia (post-cataract surgery)
• Keep CALL BELL within REACH and ensure patient knows how to use it
• Use VERBAL DESCRIPTION of procedures — explain what you are about to do and why; do not assume the patient can see your actions
• LABEL items clearly in the room if patient has some vision — use large print or Braille
• Provide AUDIO MATERIALS — radio, audiobooks, talking clock, apps for blind users (JAWS, NVDA)
• ORIENT family members to assist with patient safety and independence
• Assess MOBILITY and VISION with patient to determine safe ambulation; use assistive devices (cane, walker) as needed

Rank

1

Exam Tip

An elderly patient with blurred vision, glare, and halos—NOT pain—describes cataract. Post-op priorities are IOP precautions: no bending, lifting, straining, Valsalva, coughing; wear shield; use drops; report sudden severe pain immediately.

Why Tested

Most common lens disorder; easily confused with glaucoma; treatment is elective surgery when interferes with function, NOT based on density alone

Critical Concept

CATARACT = PAINLESS, GRADUAL LENS OPACITY

Rank

2

Exam Tip

Memorize: elevated IOP alone does NOT diagnose glaucoma; must have optic nerve cupping OR visual-field loss. Vision loss starts PERIPHERALLY (tunnel vision) and goes to CENTER last. Screening is ESSENTIAL because early disease is asymptomatic.

Why Tested

Leading preventable cause of blindness; examiners test understanding that damage is IRREVERSIBLE and goal is to HALT PROGRESSION, not restore vision

Critical Concept

GLAUCOMA = IRREVERSIBLE OPTIC NERVE DAMAGE from elevated IOP; VISION LOSS IS PERMANENT

Rank

3

Exam Tip

If you see 'SUDDEN SEVERE EYE PAIN + FIXED MID-DILATED PUPIL + HALOS + NAUSEA/VOMITING' — that is ACUTE ANGLE-CLOSURE glaucoma (ophthalmic emergency). Treatment: urgent medications + emergency laser iridotomy. If gradual, asymptomatic peripheral vision loss → open-angle glaucoma (chronic topical medications).

Why Tested

Most heavily tested distinction on NLE; opposite presentations, opposite urgency, opposite treatments

Critical Concept

OPEN-ANGLE GLAUCOMA: painless, gradual, asymptomatic early; ANGLE-CLOSURE GLAUCOMA: EMERGENCY with sudden severe pain, halos, fixed mid-dilated pupil, nausea/vomiting

Rank

4

Exam Tip

For beta-blockers (timolol): TEACH PUNCTAL OCCLUSION (press medial canthus 1–2 minutes) to reduce systemic absorption and systemic side effects. Contraindicated in asthma, COPD, bradycardia. Prostaglandin analogs cause permanent iris darkening and eyelash growth.

Why Tested

Common patient teaching point; medication adherence is the difference between vision preservation and blindness

Critical Concept

GLAUCOMA MEDICATIONS are LIFELONG; patient must take on schedule to preserve remaining vision; NEVER stop abruptly

Rank

5

Exam Tip

Red flag: sudden increase in floaters + flashes + visual-field shadow = retinal detachment until proven otherwise. Teach patient: restrict activity pre-op; after gas bubble surgery, MAINTAIN SPECIFIC HEAD POSITION (e.g., face-down) for weeks; CANNOT fly or go to high altitude while gas bubble present.

Why Tested

Time-critical condition; delay causes permanent vision loss; nursing priority is safe positioning and preventing further detachment pre-op and maintaining prescribed head position (often face-down) post-op with gas bubble

Critical Concept

RETINAL DETACHMENT: SUDDEN floaters + FLASHES of light + CURTAIN/SHADOW spreading across visual field, PAINLESS; URGENT SURGICAL EMERGENCY

Rank

6

Exam Tip

Priority during vertigo attack: SAFETY FIRST—patient lies still in quiet, dark room; prevent falls. Chronic management: LOW-SODIUM DIET (<2 g/day) + diuretics + avoid caffeine, alcohol, nicotine. Vestibular rehabilitation exercises help over time.

Why Tested

Classic presentation that examiners test; easily confused with other vertigo causes; treatment includes low-sodium diet, diuretics, vestibular suppressants

Critical Concept

MÉNIÈRE'S DISEASE = TRIAD: EPISODIC VERTIGO (sudden, severe spinning) + TINNITUS (ringing) + FLUCTUATING SENSORINEURAL HEARING LOSS; often with aural fullness

Rank

7

Exam Tip

Teaching point: Complete antibiotics; keep water out of ears if tubes present; prevent water entry. Recurrent otitis media (≥4 episodes in 6 months) or persistent OME (>3 months with hearing loss) = candidate for myringotomy and tympanostomy tube placement.

Why Tested

Explains the epidemiology and anatomy; why recurrent cases need tympanostomy tubes

Critical Concept

OTITIS MEDIA most common in CHILDREN <3 years because Eustachian tube is SHORTER, MORE HORIZONTAL, NARROWER than in adults

Rank

8

Exam Tip

When aminoglycosides are used: check baseline hearing; monitor serum levels (peak/trough); educate patient about tinnitus/hearing loss symptoms. SYNERGISTIC EFFECT: combining multiple ototoxic drugs (e.g., gentamicin + furosemide) increases risk dramatically. If hearing loss develops, consider discontinuing or substituting alternative drug.

Why Tested

Patient safety; nurses must monitor and report early signs (tinnitus, high-frequency hearing loss) to prevent permanent damage

Critical Concept

OTOTOXIC MEDICATIONS include aminoglycosides (gentamicin), loop diuretics (furosemide), high-dose aspirin/salicylates, and chemotherapy (cisplatin); cause irreversible hearing loss and tinnitus

Rank

9

Exam Tip

Weber lateralizes to WORSE ear in conductive loss (sound goes to plugged ear). Rinne shows BC > AC in conductive loss (bone pathway opens while air pathway blocked). In sensorineural, both AC and BC are decreased but AC still > BC (same pattern as normal, but reduced).

Why Tested

Tuning-fork tests are on most exams; must be able to interpret them to differentiate types of hearing loss

Critical Concept

WEBER TEST INTERPRETATION: lateralizes TO affected ear in CONDUCTIVE loss; lateralizes AWAY FROM affected ear in SENSORINEURAL loss. RINNE TEST: AC > BC (normal); BC > AC in CONDUCTIVE loss

Rank

10

Exam Tip

Common mistakes: instilling drop directly on cornea (uncomfortable, loss of drop), not occluding punctum (systemic absorption/side effects), not waiting between drops (wash-out), not closing eye gently (loss of drop). Teach patients this technique for home use.

Why Tested

Fundamental nursing skill; proper technique ensures medication efficacy and prevents complications

Critical Concept

SAFE EYE DROP INSTILLATION TECHNIQUE: wash hands, tilt head back, pull down lower lid to form pocket, instill drop (not on cornea), close eye gently, PUNCTAL OCCLUSION 1–2 minutes; wait 5 minutes between different drops; suspend/ointment LAST

Tip

ACUTE ANGLE-CLOSURE GLAUCOMA is an OPHTHALMIC EMERGENCY—if you see 'SUDDEN SEVERE EYE PAIN + FIXED MID-DILATED PUPIL + HALOS + NAUSEA/VOMITING,' answer IMMEDIATELY with 'urgent laser iridotomy' and 'lie patient down.' This is one of the few 'treat-right-now' conditions in ophthalmology on the NLE.

Context

Examiners test your ability to recognize emergencies and prioritize.

Tip Number

1

Tip

GLAUCOMA MEDICATIONS are lifelong and must be taken on SCHEDULE. Emphasize this in teaching—the patient's vision depends on adherence. NEVER tell a patient 'take as needed' for glaucoma drops; they are preventative, not curative.

Context

Medication teaching is heavily tested; this distinction is critical for patient safety.

Tip Number

2

Tip

RETINAL DETACHMENT postoperatively: if a GAS BUBBLE is used, the patient CANNOT fly or go to HIGH ALTITUDE until the gas resorbs. This is a mandatory, non-negotiable teaching point—air pressure changes can cause dangerous bubble expansion.

Context

Specific post-op precaution that examiners include in scenario questions.

Tip Number

3

Tip

WEBER and RINNE tuning-fork tests are exam favorites. Memorize: Weber lateralizes to the WORSE ear in conductive loss (sound goes to plugged ear); Rinne shows BC > AC in conductive loss (bone pathway opens while air pathway blocked). Use this mnemonic: 'Conductive loss = sound goes to the bad ear (Weber) and bone beats air (Rinne)'.

Context

Quick tuning-fork reference for differentiation questions.

Tip Number

4

Tip

MÉNIÈRE'S DISEASE teaching: LOW-SODIUM DIET (<2 g/day) + DIURETICS + avoid CAFFEINE, ALCOHOL, NICOTINE. These are the pillars of chronic management. Acute attack = safety, dark room, stillness, vestibular suppressants. Examiners love asking about both acute and chronic management.

Context

Comprehensive management is testable; diet is often overlooked by students.

Tip Number

5

Rows

Columns

• Feature
• Open-Angle Glaucoma
• Acute Angle-Closure Glaucoma

Table Title

PRIMARY OPEN-ANGLE vs. ACUTE ANGLE-CLOSURE GLAUCOMA: The Critical Distinction

Rows

Columns

• Feature
• Conductive Loss
• Sensorineural Loss

Table Title

CONDUCTIVE vs. SENSORINEURAL HEARING LOSS

Rows

Columns

• Drug Class
• Examples
• Mechanism (IOP Reduction)
• Frequency
• Key Precautions / Monitoring

Table Title

GLAUCOMA MEDICATIONS: Mechanism, Timing, & Precautions

Rows

Columns

• Feature
• Otitis Externa
• Otitis Media

Table Title

OTITIS EXTERNAL vs. OTITIS MEDIA